Yutudao Marine Biotechnology (XCAN) Stock Statistics & Valuation Metrics

Yutudao Marine Biotechnology has a market cap or net worth of $7.50K. The enterprise value is ―.

Yutudao Marine Biotechnology has 30,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Yutudao Marine Biotechnology’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Yutudao Marine Biotechnology is ―. Yutudao Marine Biotechnology’s PEG ratio is ―.

In the last 12 months, Yutudao Marine Biotechnology had revenue of ― and earned -34.76K in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Yutudao Marine Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―

Yutudao Marine Biotechnology upcoming earnings date is ―, ―.

Yutudao Marine Biotechnology as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Yutudao Marine Biotechnology has paid ― in taxes.

Yutudao Marine Biotechnology EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Yutudao Marine Biotechnology has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Yutudao Marine Biotechnology is ―, which is 11.43% higher than the current price. The consensus rating is ―